- Home
- BCRX vs ESTA Comparison
BCRX vs ESTA Comparison
Compare BCRX & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | ESTA |
|---|---|---|
| Founded | 1986 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BCRX | ESTA |
|---|---|---|
| Price | $9.52 | $56.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | $20.82 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 5.9M | 471.8K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | 42.67 |
| EPS | ★ 1.21 | N/A |
| Revenue | $25,186,000.00 | ★ $61,208,000.00 |
| Revenue This Year | N/A | $28.04 |
| Revenue Next Year | $12.55 | $26.23 |
| P/E Ratio | $7.83 | ★ N/A |
| Revenue Growth | N/A | ★ 76.49 |
| 52 Week Low | $6.00 | $26.56 |
| 52 Week High | $11.31 | $83.31 |
Technical Indicators
Market Signals| Indicator | BCRX | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 64.59 | 32.22 |
| Support Level | $7.85 | $36.41 |
| Resistance Level | $10.32 | $68.38 |
| Average True Range (ATR) | 0.60 | 3.59 |
| MACD | -0.03 | -0.80 |
| Stochastic Oscillator | 65.44 | 26.78 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.